Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hallengärd

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Expert Review of Vaccines|February 7, 2008
Challenges of Global Vaccine DevelopmentLindvi Gudmundsdotter, David Hallengärd
Viral Immunology|April 12, 2013
A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicityDavid Hallengärd, Britta Wahren, Andreas Bråve
Vaccine|May 3, 2008
Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responsesAndreas Bråve, David Hallengärd, Ulf Schröder, et al.
Vaccine|March 18, 2014
Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high dosesIngrid Lindh, Andreas Bråve, David Hallengärd, et al.
Vaccine|November 11, 2008
Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responsesAndreas Bråve, David Hallengärd, Maria Malm, et al.
Vaccine|May 12, 2009
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigenAndreas Bråve, David Hallengärd, Lindvi Gudmundsdotter, et al.
Clinical and Vaccine Immunology : CVI|July 15, 2011
Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporationDavid Hallengärd, B Kristian Haller, Anna-Karin Maltais, et al.
Genetic Vaccines and Therapy|August 10, 2012
A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccinesDavid Hallengärd, Andreas Bråve, Maria Isaguliants, et al.
Journal of Virology|January 10, 2014
A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infectionJuan García-Arriaza, Victoria Cepeda, David Hallengärd, et al.
Vaccine|January 2, 2010
Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytesAndreas Brave, Ulrika Johansson, David Hallengärd, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Expert Review of Vaccines|February 7, 2008
Challenges of Global Vaccine DevelopmentLindvi Gudmundsdotter, David Hallengärd
Viral Immunology|April 12, 2013
A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicityDavid Hallengärd, Britta Wahren, Andreas Bråve
Vaccine|May 3, 2008
Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responsesAndreas Bråve, David Hallengärd, Ulf Schröder, et al.
Vaccine|March 18, 2014
Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high dosesIngrid Lindh, Andreas Bråve, David Hallengärd, et al.
Vaccine|November 11, 2008
Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responsesAndreas Bråve, David Hallengärd, Maria Malm, et al.
Vaccine|May 12, 2009
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigenAndreas Bråve, David Hallengärd, Lindvi Gudmundsdotter, et al.
Clinical and Vaccine Immunology : CVI|July 15, 2011
Comparison of plasmid vaccine immunization schedules using intradermal in vivo electroporationDavid Hallengärd, B Kristian Haller, Anna-Karin Maltais, et al.
Genetic Vaccines and Therapy|August 10, 2012
A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccinesDavid Hallengärd, Andreas Bråve, Maria Isaguliants, et al.
Journal of Virology|January 10, 2014
A novel poxvirus-based vaccine, MVA-CHIKV, is highly immunogenic and protects mice against chikungunya infectionJuan García-Arriaza, Victoria Cepeda, David Hallengärd, et al.
Vaccine|January 2, 2010
Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytesAndreas Brave, Ulrika Johansson, David Hallengärd, et al.
Pageof 3